Cancer de la prostate sensible à la castration et métastatique
Cancer de la prostate sensible à la castration et métastatique
COMITÉ ÉDITORIAL : Ricardo Rendon and Troy Sitland
This tool card, developed for urologists and medical oncologists, supports identification of patients with advanced prostate cancer experiencing disease progression that requires a new treatment strategy - specifically patients with diagnosed metastatic castration-sensitive prostate cancer (mCSPC).
Ce programme a reçu le soutien financier de Janssen sous la forme d'une subvention à l'éducation.